What is Life2?
Life2 operates at the intersection of artificial intelligence and healthcare, offering its AI Cycle Platform designed to predict and mitigate individual patient risks in real-time. This innovative approach aims to reduce healthcare expenditures while simultaneously elevating patient care standards. Through its Claustrum AI service, Life2 provides granular, per-person risk rankings and actionable intervention strategies, empowering healthcare organizations to optimize outcomes and foster improved population health.
How much funding has Life2 raised?
Life2 has raised a total of $1.5M across 1 funding round:
Series A
$1.5M
Series A (2017): $1.5M, investors not publicly disclosed
What's next for Life2?
The substantial enterprise-level backing positions Life2 for accelerated growth and market penetration. With a focus on enhancing clinical, operational, and financial metrics, the company is poised to further refine its AI-driven risk prediction and mitigation capabilities. This strategic investment will likely fuel expansion into new healthcare markets and deepen its existing partnerships, solidifying its role as a key player in data-driven healthcare transformation.
See full Life2 company page
